Fees in Respect of Dealer’s Licences Regulations

Marginal note:Purpose — fees

• 2 (1) The purpose of these Regulations is to prescribe the fees for

  • (a) the examination of a new drug submission, a supplement to a new drug submission, an abbreviated new drug submission or a supplement to an abbreviated new drug submission referred to in section C.08.002, C.08.002.1 or C.08.003 of the Food and Drug Regulations, an application in respect of an establishment licence under those Regulations or an application for a drug identification number under section C.01.014.1 of those Regulations;

  • (b) the examination of an application for, or the renewal of, a dealer’s licence under Part G of the Food and Drug Regulations or under the Narcotic Control Regulations;

  • (c) the right to sell a drug under the Food and Drug Regulations; and

  • (d) the examination of an application in respect of a medical device licence, the right to sell a medical device or the examination of an application in respect of an establishment licence under the Medical Devices Regulations.

• Marginal note:Purpose — remission

  (2) The purpose of these Regulations is also to remit, in whole or in part, certain of those fees.